tiprankstipranks
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
US Market

Telomir Pharmaceuticals, Inc. (TELO) Revenue

210 Followers

Telomir Pharmaceuticals, Inc. Revenue

Telomir Pharmaceuticals, Inc. had a revenue of 0.00 in the quarter ending Dec 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Telomir Pharmaceuticals, Inc. had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
1
Market Cap
$41.94M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021